Table 3.
Complications by Clavien-Dindo grade (I-V)
| Author | Reported Complications | Grade I-II | Grade III-IV | Grade V |
|---|---|---|---|---|
| Benamran et al. 2022 [21] | 2 (10%) | 1 (Pain and Anxiety) | 1 (Hematoma) | 0 |
| Bernhard et al. 2022 [19] | 7 (8.5%) | 7 (tramadol induced hallucinations, pain, nausea, anxiety, delayed voiding) | 0 | 0 |
| Gangidi et al. 2025 [9] | 4 (9.1%) | NA | NA | NA |
| Mehrazin et al. 2020 [18] | 1 (4.3%), Urinary retention | NA | NA | NA |
| Wald et al. 2024 [20] | 1 (4.8%) | 1 (Wound infection) | 0 | 0 |
| Wood et al. 2023 [11] | NA | NA | NA | NA |